The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery
Key facts
- Who runs it
- Zhejiang University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 227 people enrolled
- Started
- 1 Jun 2025
- Ended
- 2 Jun 2026
- Type of study
- Interventional
- Treatments tested
- oxytocin nasal spray
- Record updated
- 20 August 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Age ≥ 65 years
- Patients who were to undergo elective orthopedic surgery under general anesthesia with tracheal intubation
- ASA class I-III
- Estimated duration of surgery ≥ 1 hour; (5) The patient himself/herself or his/her legal representative
- Informed consent from the patient or legal representative
- Proficiency in the use of Chinese language for communication
Who cannot take part
- Patients with previous psychiatric and neurological disorders, such as depression, severe central nervous system depression, Parkinson's disease, basal ganglia disease; Goldson's disease, basal ganglia lesions, schizophrenia, epilepsy, Alzheimer's disease, myasthenia gravis, and so on
- Preoperative cognitive impairment as determined by a MoCA evaluation prior to surgery
- Patients who are scheduled for 2 surgeries within 7 days of surgery
- Oxytocin allergy
- Patients with severe hepatic insufficiency (Child-Pugh class C)
- patients with severe renal insufficiency (dialysis is required before surgery)
- Severe heart failure (METS<4)
- Preoperative inability to communicate (coma or dementia)
- Patients with bone malignancy
- Nasal cavity occupation, patients with fillers in the nose
- Pregnant and lactating women
- Severe preoperative blindness, deafness, or inability to understand Mandarin to complete preoperative delirium screening
- Currently participating in other clinical trials
Other criteria
- Elderly patients undergoing orthopedic surgery under general anesthesia
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postoperative delirium is a delirium that occurs within 7 days after surgery or before hospital discharge. It has been shown that combined POD can increase the incidence of postoperative pulmonary infections, deep vein thrombosis and decubitus ulcers, and increase the incidence of disability and mortality. The incidence of postoperative delirium in geriatric orthopedics is high.
Read full original descriptionShow less
Investigators conduct a prospective clinical study on geriatric orthopedic surgery patients to investigate the effect of oxytocin nasal spray on the prevention of postoperative delirium in geriatric orthopedic surgery. Cases were included according to the inclusion and exclusion criteria, and induction, maintenance and resuscitation were performed according to the standard protocol for general anesthesia. Before the end of surgery, the Investigators administered oxytocin nasal spray (Oxytocin) that was 3 sprays in each nostril (4 IU each) for a total of 24 IU. Beginning 1 day postoperatively, administer 24 IU of oxytocin nasal spray 2 times/day in the morning and in the evening. Until 7 days after surgery or discharge. The sample size are 77 cases in phase I and 143 cases in phase 2, total 220 cases.
The group in the trial
- Oxytocin nasal spray given to geriatric orthopedic general anesthesia patientsTreatment being tested
Cases were included according to the inclusion and exclusion criteria, and induction, maintenance and resuscitation were performed according to the standard protocol for general anesthesia.Before the end of anesthesia, the experimenter administered oxytocin nasal spray (Oxytocin) that was 3 sprays in each nostril (4 IU each) for a total of 24 IU. Beginning 1 day postoperatively, administer 24 IU of oxytocin nasal spray 2 times/day in the morning and 24 IU in the evening.Until 7 days after surgery or discharge.
Treatment: oxytocin nasal spray
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery:Two-Stage Designs for Phase II Clinical Trials
- Record updated
- 20 August 2026